Evidence map›Paper›PMID 41567213›Full record

ArticleFrontiers in immunology2025

Ulcerative colitis model triggers gut α-Synuclein aggregation without brain involvement or neuronal loss in female rats.

Ana María Espinosa-Oliva, María Dolores Vázquez-Carretero, Rocío Ruiz, María A Roca-Ceballos, Pablo García-Miranda, María José Peral, Manuel Sarmiento Soto, Antonio J Herrera, José Luis Venero, Rocío M de Pablos

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ana María Espinosa-OlivaInstituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Seville, Sevilla, Spain.
María Dolores Vázquez-CarreteroFacultad de Farmacia, Departamento de Fisiología, Universidad de Sevilla, Seville, Spain.
Rocío RuizInstituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Seville, Sevilla, Spain.
María A Roca-CeballosInstituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Seville, Sevilla, Spain.
Pablo García-MirandaFacultad de Farmacia, Departamento de Fisiología, Universidad de Sevilla, Seville, Spain.
María José PeralFacultad de Farmacia, Departamento de Fisiología, Universidad de Sevilla, Seville, Spain.
Manuel Sarmiento SotoInstituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Seville, Sevilla, Spain.
Antonio J HerreraInstituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Seville, Sevilla, Spain.
José Luis VeneroInstituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Seville, Sevilla, Spain.
Rocío M de PablosInstituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Seville, Sevilla, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Despite being the second most common neurodegenerative disorder, the mechanisms underlying the onset and progression of Parkinson's disease (PD) remain poorly understood, and no curative treatment is currently available. The Braak hypothesis offers an intriguing framework for explaining both the origin and development of the disease, proposing that PD begins in the gut and subsequently spreads to the brain. Methods: In previous studies, our group developed a novel PD model in which peripheral inflammation, triggered by administering dextran sodium sulphate (DSS) in the drinking water of male Wistar rats, recapitulates key features of PD in both the gut and the brain. This model supports the Braak hypothesis and highlights the relevance of the gut-brain axis. Using the same model, the present study aimed to determine whether sex influences peripheral inflammation and the resulting neuropathology in the substantia nigra (SN) of female Wistar rats. Results: Our findings show that while DSS treatment induces comparable levels of colonic inflammation and phosphorylated α-synuclein accumulation in both sexes, it does not produce α-synuclein aggregation or dopaminergic neuronal loss in the SN pars compacta of female rats. Conclusion: These results underscore the critical importance of considering sex differences in experimental PD models and in clinical practice, as such differences may significantly influence PD pathogenesis.

Indexed as

alpha-SynucleinBrainAnimalsColitisColonDextran SulfateDisease Models, AnimalDopaminergic NeuronsFemaleMaleParkinson DiseaseRatsRats, WistarSex FactorsSubstantia Nigraalpha-SynucleinDextran Sulfategut-brain axisinflammationneurodegenerationParkinson diseasesex differencesulcerative colitisα-Synuclein

Identifiers

PMID41567213
PMCPMC12815745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.